FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000449009> ?p ?o ?g. }

• W2000449009 endingPage "90" @default.
• W2000449009 startingPage "78" @default.
• W2000449009 abstract "Ovarian cancer has a clear predilection to metastasize to the peritoneum, which represents one of the most important prognostic factors of poor clinical outcome. Gonadotropin-releasing hormone (GnRH) receptor is significantly overexpressed during the malignant progression of human ovarian cancer. Here, using lentiviral-based small interfering RNA (siRNA) technology to downregulate GnRH receptor in metastatic ovarian cancer cells, we show that GnRH receptor is an important mediator of ovarian cancer peritoneal metastasis. GnRH receptor downregulation dramatically attenuated their adhesion to the peritoneal mesothelium. By inhibiting the expression of GnRH receptor, we showed decreased expression of α2β1 and α5β1 integrin and adhesion to specific extracellular matrix (ECM) proteins. This was also associated with a reduction of P-cadherin. Furthermore, adhesion of ovarian cancer cells to different ECMs and the mesothelium were abrogated in response to β1 integrin and P-cadherin reduction, confirming that the effects were β1 integrin- and P-cadherin–specific. Using a mouse model of human ovarian cancer metastasis, we found that the inhibition of GnRH receptor, β1 integrin, and P-cadherin significantly attenuated tumor growth, ascites formation, and the number of metastatic implants. These results define a new role for GnRH receptor in early metastasis and offer the possibility of novel therapeutic targets. Ovarian cancer has a clear predilection to metastasize to the peritoneum, which represents one of the most important prognostic factors of poor clinical outcome. Gonadotropin-releasing hormone (GnRH) receptor is significantly overexpressed during the malignant progression of human ovarian cancer. Here, using lentiviral-based small interfering RNA (siRNA) technology to downregulate GnRH receptor in metastatic ovarian cancer cells, we show that GnRH receptor is an important mediator of ovarian cancer peritoneal metastasis. GnRH receptor downregulation dramatically attenuated their adhesion to the peritoneal mesothelium. By inhibiting the expression of GnRH receptor, we showed decreased expression of α2β1 and α5β1 integrin and adhesion to specific extracellular matrix (ECM) proteins. This was also associated with a reduction of P-cadherin. Furthermore, adhesion of ovarian cancer cells to different ECMs and the mesothelium were abrogated in response to β1 integrin and P-cadherin reduction, confirming that the effects were β1 integrin- and P-cadherin–specific. Using a mouse model of human ovarian cancer metastasis, we found that the inhibition of GnRH receptor, β1 integrin, and P-cadherin significantly attenuated tumor growth, ascites formation, and the number of metastatic implants. These results define a new role for GnRH receptor in early metastasis and offer the possibility of novel therapeutic targets." @default.
• W2000449009 created "2016-06-24" @default.
• W2000449009 creator A5010677692 @default.
• W2000449009 creator A5011859890 @default.
• W2000449009 creator A5015170367 @default.
• W2000449009 creator A5028662303 @default.
• W2000449009 creator A5083611772 @default.
• W2000449009 date "2013-01-01" @default.
• W2000449009 modified "2023-10-17" @default.
• W2000449009 title "Targeting Gonadotropin-releasing Hormone Receptor Inhibits the Early Step of Ovarian Cancer Metastasis by Modulating Tumor-mesothelial Adhesion" @default.
• W2000449009 cites W130422265 @default.
• W2000449009 cites W1554900315 @default.
• W2000449009 cites W168898604 @default.
• W2000449009 cites W1856257838 @default.
• W2000449009 cites W1973990676 @default.
• W2000449009 cites W1978467605 @default.
• W2000449009 cites W1982817261 @default.
• W2000449009 cites W1984626255 @default.
• W2000449009 cites W1985671292 @default.
• W2000449009 cites W1988078820 @default.
• W2000449009 cites W2000269194 @default.
• W2000449009 cites W2002419309 @default.
• W2000449009 cites W2010441567 @default.
• W2000449009 cites W2020977820 @default.
• W2000449009 cites W2026675261 @default.
• W2000449009 cites W2027889831 @default.
• W2000449009 cites W2029231027 @default.
• W2000449009 cites W2032930150 @default.
• W2000449009 cites W2051239163 @default.
• W2000449009 cites W2064538929 @default.
• W2000449009 cites W2078406396 @default.
• W2000449009 cites W2078950638 @default.
• W2000449009 cites W2080442169 @default.
• W2000449009 cites W2082513866 @default.
• W2000449009 cites W2083405430 @default.
• W2000449009 cites W2084457841 @default.
• W2000449009 cites W2091721680 @default.
• W2000449009 cites W2096392827 @default.
• W2000449009 cites W2098275650 @default.
• W2000449009 cites W2106411439 @default.
• W2000449009 cites W2121080406 @default.
• W2000449009 cites W2129254986 @default.
• W2000449009 cites W2136138562 @default.
• W2000449009 cites W2155269388 @default.
• W2000449009 cites W2165948908 @default.
• W2000449009 doi "https://doi.org/10.1038/mt.2012.187" @default.
• W2000449009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3538308" @default.
• W2000449009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23164934" @default.
• W2000449009 hasPublicationYear "2013" @default.
• W2000449009 type Work @default.
• W2000449009 sameAs 2000449009 @default.
• W2000449009 citedByCount "19" @default.
• W2000449009 countsByYear W20004490092014 @default.
• W2000449009 countsByYear W20004490092015 @default.
• W2000449009 countsByYear W20004490092016 @default.
• W2000449009 countsByYear W20004490092017 @default.
• W2000449009 countsByYear W20004490092018 @default.
• W2000449009 countsByYear W20004490092019 @default.
• W2000449009 countsByYear W20004490092020 @default.
• W2000449009 countsByYear W20004490092021 @default.
• W2000449009 countsByYear W20004490092023 @default.
• W2000449009 crossrefType "journal-article" @default.
• W2000449009 hasAuthorship W2000449009A5010677692 @default.
• W2000449009 hasAuthorship W2000449009A5011859890 @default.
• W2000449009 hasAuthorship W2000449009A5015170367 @default.
• W2000449009 hasAuthorship W2000449009A5028662303 @default.
• W2000449009 hasAuthorship W2000449009A5083611772 @default.
• W2000449009 hasBestOaLocation W20004490091 @default.
• W2000449009 hasConcept C104317684 @default.
• W2000449009 hasConcept C121608353 @default.
• W2000449009 hasConcept C126322002 @default.
• W2000449009 hasConcept C127561419 @default.
• W2000449009 hasConcept C134018914 @default.
• W2000449009 hasConcept C142724271 @default.
• W2000449009 hasConcept C22615655 @default.
• W2000449009 hasConcept C2776001837 @default.
• W2000449009 hasConcept C2776817873 @default.
• W2000449009 hasConcept C2778575703 @default.
• W2000449009 hasConcept C2778894405 @default.
• W2000449009 hasConcept C2779013556 @default.
• W2000449009 hasConcept C2779256057 @default.
• W2000449009 hasConcept C2779747549 @default.
• W2000449009 hasConcept C2780427987 @default.
• W2000449009 hasConcept C502942594 @default.
• W2000449009 hasConcept C54009773 @default.
• W2000449009 hasConcept C54355233 @default.
• W2000449009 hasConcept C55493867 @default.
• W2000449009 hasConcept C71315377 @default.
• W2000449009 hasConcept C71924100 @default.
• W2000449009 hasConcept C81885089 @default.
• W2000449009 hasConcept C86803240 @default.
• W2000449009 hasConceptScore W2000449009C104317684 @default.
• W2000449009 hasConceptScore W2000449009C121608353 @default.
• W2000449009 hasConceptScore W2000449009C126322002 @default.
• W2000449009 hasConceptScore W2000449009C127561419 @default.
• W2000449009 hasConceptScore W2000449009C134018914 @default.
• W2000449009 hasConceptScore W2000449009C142724271 @default.
• W2000449009 hasConceptScore W2000449009C22615655 @default.

• next